DAZHONG DENTAL (02651): Board Schedules 31 Mar 2026 Meeting to Approve FY2025 Results and Potential Final Dividend

Bulletin Express

03/19

Wuhan Dazhong Dental Medical Co., Ltd. (DAZHONG DENTAL, 02651) has fixed Tuesday, 31 March 2026, for a board meeting dedicated to key fiscal deliberations.

The agenda includes: 1. Reviewing and approving the consolidated annual results for the financial year ended 31 December 2025. 2. Authorising the public release of those results. 3. Considering a recommendation for a final dividend, if any, to be put forward to shareholders.

The meeting will be chaired by Mr. Yao Xue, who serves as Chairman and Executive Director. The board currently consists of four executive directors—Mr. Yao Xue, Ms. Shen Hongmin, Mr. Guo Jiaping and Ms. Liu Hongchan—alongside three independent non-executive directors—Mr. Shu Yijie, Ms. Huang Suzhen and Mr. Xie Dong.

The company released the scheduling notice on 19 March 2026 in Wuhan, Hubei Province, in accordance with Hong Kong listing rules and disclosure requirements.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1190027791"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1190027791\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1190027791?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-19 18:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1190027791","market":"us","top_or_hot":-1,"title":"DAZHONG DENTAL (02651): Board Schedules 31 Mar 2026 Meeting to Approve FY2025 Results and Potential Final Dividend","media":"Bulletin Express","content":"<p>Wuhan Dazhong Dental Medical Co., Ltd. (DAZHONG DENTAL, 02651) has fixed Tuesday, 31 March 2026, for a board meeting dedicated to key fiscal deliberations.</p>\n<p>The agenda includes:  \n1. Reviewing and approving the consolidated annual results for the financial year ended 31 December 2025.  \n2. Authorising the public release of those results.  \n3. Considering a recommendation for a final dividend, if any, to be put forward to shareholders.</p>\n<p>The meeting will be chaired by Mr. Yao Xue, who serves as Chairman and Executive Director. The board currently consists of four executive directors—Mr. Yao Xue, Ms. Shen Hongmin, Mr. Guo Jiaping and Ms. Liu Hongchan—alongside three independent non-executive directors—Mr. Shu Yijie, Ms. Huang Suzhen and Mr. Xie Dong.</p>\n<p>The company released the scheduling notice on 19 March 2026 in Wuhan, Hubei Province, in accordance with Hong Kong listing rules and disclosure requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DAZHONG DENTAL (02651): Board Schedules 31 Mar 2026 Meeting to Approve FY2025 Results and Potential Final Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDAZHONG DENTAL (02651): Board Schedules 31 Mar 2026 Meeting to Approve FY2025 Results and Potential Final Dividend\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-03-19 18:43</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Wuhan Dazhong Dental Medical Co., Ltd. (DAZHONG DENTAL, 02651) has fixed Tuesday, 31 March 2026, for a board meeting dedicated to key fiscal deliberations.</p>\n<p>The agenda includes:  \n1. Reviewing and approving the consolidated annual results for the financial year ended 31 December 2025.  \n2. Authorising the public release of those results.  \n3. Considering a recommendation for a final dividend, if any, to be put forward to shareholders.</p>\n<p>The meeting will be chaired by Mr. Yao Xue, who serves as Chairman and Executive Director. The board currently consists of four executive directors—Mr. Yao Xue, Ms. Shen Hongmin, Mr. Guo Jiaping and Ms. Liu Hongchan—alongside three independent non-executive directors—Mr. Shu Yijie, Ms. Huang Suzhen and Mr. Xie Dong.</p>\n<p>The company released the scheduling notice on 19 March 2026 in Wuhan, Hubei Province, in accordance with Hong Kong listing rules and disclosure requirements.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02651","symbol_name":"大眾口腔","start_time":0,"source_url":"","article_id":"1190027791","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1190027791","pubTimestamp":1773917008,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Wuhan Dazhong Dental Medical Co., Ltd. (DAZHONG DENTAL, 02651) has fixed Tuesday, 31 March 2026, for a board meeting dedicated to key fiscal deliberations. The agenda includes:   1. Reviewing and...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02651":"大众口腔"},"translate_title":"大众口腔(02651)：董事会定于2026年3月31日召开会议批准2025财年业绩及潜在末期股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02651":1},"content_text":"Wuhan Dazhong Dental Medical Co., Ltd. (DAZHONG DENTAL, 02651) has fixed Tuesday, 31 March 2026, for a board meeting dedicated to key fiscal deliberations.\nThe agenda includes:  \n1. Reviewing and approving the consolidated annual results for the financial year ended 31 December 2025.  \n2. Authorising the public release of those results.  \n3. Considering a recommendation for a final dividend, if any, to be put forward to shareholders.\nThe meeting will be chaired by Mr. Yao Xue, who serves as Chairman and Executive Director. The board currently consists of four executive directors—Mr. Yao Xue, Ms. Shen Hongmin, Mr. Guo Jiaping and Ms. Liu Hongchan—alongside three independent non-executive directors—Mr. Shu Yijie, Ms. Huang Suzhen and Mr. Xie Dong.\nThe company released the scheduling notice on 19 March 2026 in Wuhan, Hubei Province, in accordance with Hong Kong listing rules and disclosure requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}